Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  He, Tongrong ^a   Weintraub, Neal L ^a   Goswami, Prabhat C ^a   Chatterjee, Papri ^a   Flaherty, Dawn M ^a   Domann, Frederick E ^a   Oberley, Larry W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Activator protein 1; Antisense; Cell cycle

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; REDOX EFFECTOR FACTOR 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE TRANSFER; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0038299343     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01080.2002     Document Type: Article

References (48)

1. Abate C, Patel L, Pauscher FJ III, and Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249: 1157-1161, 1990.
2. Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B, and Pestell R. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 274: 34186-34195, 1999.
3. 2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275: 10527-10531, 2000.
4. Boota A, Johnson B, Lee KL, Blaskovich MA, Liu SX, Kagan VE, Hamilton A, Pitt B, Sebti SM, and Davies P. Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 278: L329-L334, 2000.
5. Brown MR, Miller FJ Jr, Li WG, Ellingson AN, Mozena JD, Chatterjee P, Engelhardt JF, Zwacka RM, Oberley L W, Fang X, Spector AA, and Weintraub NL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 85: 524-533, 1999.
6. a. Crowe DL, Brown TN, Kim R, Smith SM, and Lee MK. A c-fos/estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines. Mol Cell Biol Res Commun 3: 243-248, 2000.
7. Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A, and Barzilai A. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-κB via Ref-1. J Biol Chem 276: 1335-1344, 2001.
8. Dalton TP, Shertzer HZ, and Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxical 39: 67-101, 1999.
9. Diamond DA, Parsian A, Hunt CR, Lofgren S, Spitz DR, Goswami PC, and Gius D. Redox factor-1 (Ref-1) mediates the activation of AP-1 in Hela and NIH 3T3 cells in response to heat shock. J Biol Chem 274: 16959-16964, 1999.
10. Fang X, Kaduce TL, Weintraub NL, Van Rollins M, and Spector AA. Functional implications of a newly characterized pathway of 11, 12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. Circ Res 79: 784-793, 1996.
11. Flaherty DM, Monick MM, Carter AB, Peterson MW, and Hunninghake GW. Oxidant-mediated increase in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages. J Immunol 168: 5675-5681, 2002.
12. Galter D, Mihm S, and Droge W. Distinct effects of glutathione disulphide on the nuclear transcription factor κB and the activator protein-1. Eur J Biochem 221: 639-648, 1994.
13. Gius D, Botero A, Shah S, and Curry HA. Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol Lett 106: 93-106, 1999.
14. 1-transit following transient inhibition of DNA replication is dependent on two processes. Exp Cell Res 214: 198-208, 1994.
15. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
16. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
17. Heldin CH and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999.
18. Higashikubo R, Ragouzis M, and Roti Roti JL. Flow cytometric BrdUrd-pulse-chase study of X-ray induced alterations in cell cycle progression. Cell Prolif 29: 43-57, 1996.
19. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1, Proc Natl Acad Sci USA 94: 3633-3638, 1997.
20. Huang Y and Domann FE. Redox modulation of AP-2 DNA binding activity in vitro. Biochem Biophys Res Commun 249: 307-312, 1998.
21. Iantomasi T, Favilli F, Degl'Innocenti D, and Vincenzini MT. Increased glutathione synthesis associated with platelet-derived growth factor stimulation of NIH3T3 fibroblasts. Biochim Biophys Acta 1452: 303-312, 1999.
22. Irani K and Coldschmidt-Clermont PJ. Ras, superoxide and signal transduction. Biochem Pharmacol 55: 1339-1346, 1998.
23. Jayaraman L, Murht KGK, Zhu C, Curran T, Xanthoudaki S, and Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11: 558-570, 1997.
24. Kakolyris S, Kaklamanis L, Giatromanoki A, Koukourakis M, Hickson ID, Barzilay G, Turley H, Leek RD, Kanavaros P, Georgoulias V, Gatter KC, and Harris AL. Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 330: 561-569, 1998.
25. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, and Koch M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 7: 824-30, 2001.
26. Lando D, Pongratz I, Poellinger L, and Whitelaw ML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J Biol Chem 275: 4618-27, 2000.
27. -· production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276: 29251-29256, 2001.
28. Milde-Langosch K, Bamberger AM, Methner C, Rieck G, and Loning T. Expression of cell cycle-regulatory protein Rb, p16/MTS1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activation protein family members. Int J Cancer 87: 468-472, 2000.
29. 2 in Swiss 3T3 fibroblasts. J Biol Chem 273: 29986-29994, 1998.
30. Moore DH, Michael H, Tritt R, Parsons SH, and Kelley MR. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res 6: 602-609 2000.
31. Ohtsubo M and Roberts JM. Cyclin-dependent regulation of G1 in mammalian cells. Science 259: 1908-1912, 1993.
32. Powis G, Briehl M, and Oblong J. Redox signaling and the control of cell growth and death. Pharmacol Ther 68: 149-73, 1995.
33. Raines EW and Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69, Suppl 1: S30-S37, 1993.
34. Rao GN, Katki KA, Madamanchi NR, Wu Y, and Birrer MJ. Jun B forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J Biol Chem 270: 6003-6010, 1999.
35. Rhee SG. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53-59, 1999.
36. Rothwell DG, Barzilay G, Gorman M, Morera S, Freemont P, and Hickson ID. The structure and functions of the HAP1/Ref-1 protein. Oncol Res 9: 275-280, 1997.
37. Sorescu D, Somers MJ, Lassegue B, Grant S, Harrison DG, and Griendling KK. Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med 30: 603-612, 2001.
38. Stein CA. The experimental use of antisense oligonucleotides: a guide for the perplexed. J Clin Invest 108: 641-644, 2001.
39. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
40. Sun Y and Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med 21: 335-348, 1996.
41. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
42. Tell G, Zecca A, Pellizzari L, Spessotto P, Colombatti A, Kelley MR, Damante G, and Pucillo C. An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/PAX-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res 28: 1099-1105, 2000.
43. Walker LJ, Robson CN, Black E, Gillespie D, and Hickson ID. Identification of residues in the human DNA repair enzyme (HAP1) Ref-1 that are essential for redox regulation of Jun DNA binding. Mol Cell Biol 13: 5370-5376, 1993.
44. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, and Gius D. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 60: 6688-6695, 2000.
45. Xanthoudakis S and Curran T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. In: Biological Reactive Intermediates V, edited by Snyder RR. New York: Plenum, 1996, p. 69-75.
46. Xanthoudakis S and Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665, 1992.
47. Xanthoudakis S, Miao GG, Wang F, Pan YC, and Curran T. Redox activation of fos-jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 11: 3323-3335, 1992.
48. Xu Y, Moore DH, Broshears J, Liu LF, Wilson TM, and Kelley MR. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 17: 3713-3719, 1997.